Human rotavirus, live, attenuated, rix strain
Rotarix Oral Suspension (Oral Applicator)
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Sciences Authority / data.gov.sg
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Human rotavirus, live, attenuated, rix strain
- Strength
- Not less than 10⁶ CCID₅₀/dose
- Dosage form
- suspension
- Route
- oral
- Register
- Singapore (HSA)
- Status
- Authorised
- Status in the register
- Registered
- Authorised
- 4 Dec 2009
- Registration
- SIN13743P
- Marketing authorisation holder
- Glaxosmithkline Pte LTD